Sizes of these terms reflect their relevance to your search.
Due to financial constraints, a patient with Wilson disease required transitioning his maintenance pharmacotherapy from zinc acetate to zinc gluconate. Herein, we report the clinical and laboratory outcomes of this switch and review the relevant literature on the treatment of Wilson disease with zinc. Zinc gluconate can be a viable treatment option for patients with Wilson disease and may be associated with fewer gastrointestinal side effects than zinc acetate and, accordingly, improved long-term compliance and improved clinical outcomes. © 2024 The Author(s).
Citation
Mark S LeDoux. Zinc gluconate for Wilson disease. Clinical parkinsonism & related disorders. 2024;11:100272
PMID: 39434848
View Full Text
